secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001641172-25-014689
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus Therapeutics shareholders approve reverse stock split authorization at annual meeting
--------------------------------------------------------------------------------

- Elected Class I directors: Gilbert, Karah, Martell; each received ~3.4M votes for.
- Ratified Haskell & White LLP as independent auditor for FY2025 (7,416,332 for).
- Advisory say-on-pay approved: 3,346,942 for, 768,207 against.
- Reverse stock split amendment approved (6,777,054 for); ratio 1:5 to 1:28, board discretion.
- Approximately 52% of outstanding shares (8,386,348) were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225014689/0001641172-25-014689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225014689/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-014689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer